Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors.
Journal: Investigational new drugs
Published: February 13, 2023
Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer.
Journal: Radiology. Imaging cancer
Published: February 03, 2023
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Journal: Gynecologic oncology
Published: October 26, 2022
IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin-paclitaxel, with or without bevacizumab in patients with advanced cancer.
Journal: Journal for immunotherapy of cancer
Published: March 03, 2022
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2021
Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial.
Journal: Cancer chemotherapy and pharmacology
Published: June 23, 2021
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 16, 2020
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase.
Journal: Breast cancer research and treatment
Published: July 15, 2020
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 10, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy.
Journal: Breast cancer research and treatment
Published: May 17, 2020
Last Updated: 09/26/2026